Ardent Health Partners (NYSE:ARDT) Price Target Lowered to $21.00 at Truist Financial

Ardent Health Partners (NYSE:ARDT) had its price objective decreased by research analysts at Truist Financial from $22.00 to $21.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s price target would suggest a potential upside of 28.44% from the company’s previous close.

ARDT has been the subject of a number of other research reports. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $20.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Leerink Partners lifted their price target on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 12th. Royal Bank of Canada restated an “outperform” rating and issued a $23.00 price objective on shares of Ardent Health Partners in a research note on Thursday, November 14th. Bank of America lowered shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and decreased their target price for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. Finally, Stephens reissued an “overweight” rating and issued a $24.00 price target on shares of Ardent Health Partners in a research report on Thursday, September 19th. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $22.00.

Ardent Health Partners Stock Up 2.7 %

Shares of ARDT opened at $16.35 on Monday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The company’s 50-day moving average is $16.66. Ardent Health Partners has a 52 week low of $14.57 and a 52 week high of $20.72.

Institutional Trading of Ardent Health Partners

A number of hedge funds and other institutional investors have recently made changes to their positions in ARDT. BNP Paribas Financial Markets bought a new stake in Ardent Health Partners during the 3rd quarter worth about $42,000. Financial Management Professionals Inc. bought a new stake in shares of Ardent Health Partners during the third quarter valued at approximately $50,000. MetLife Investment Management LLC acquired a new stake in shares of Ardent Health Partners in the third quarter valued at approximately $135,000. JPMorgan Chase & Co. bought a new position in Ardent Health Partners in the 3rd quarter worth approximately $154,000. Finally, Quadrature Capital Ltd acquired a new position in Ardent Health Partners during the 3rd quarter worth $229,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.